52 in 52 – #25: Association of Rivaroxaban vs. Apixaban With Major Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation
The 52 in 52 series returns with #25,w which looks at risk of major ischemic or hemorrhagic event with rivaroxaban versus apixaban.